These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 17123286

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Model for end-stage liver disease (MELD) exception guidelines.
    Wiesner R, Lake JR, Freeman RB, Gish RG.
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S85-7. PubMed ID: 17123285
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Model for end-stage liver disease (MELD) exception for severe pruritus.
    Washburn WK, Gish RG.
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S119. PubMed ID: 17123292
    [No Abstract] [Full Text] [Related]

  • 5. Model for end-stage liver disease (MELD) exception for unusual metabolic liver diseases.
    McDiarmid S, Gish RG, Horslen S, Mazariegos GV.
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S124-7. PubMed ID: 17123278
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Model for end-stage liver disease (MELD) exception for ascites.
    Biggins SW, Colquhoun S, Gish RG, Runyon BA.
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S88-90. PubMed ID: 17123288
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Model for end-stage liver disease (MELD) exception for primary hyperoxaluria.
    Horslen S, Gish RG, McDonald R.
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S117-8. PubMed ID: 17123291
    [No Abstract] [Full Text] [Related]

  • 10. Model for end-stage liver disease (MELD) exception for Budd-Chiari syndrome.
    Washburn WK, Gish RG, Kamath PS.
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S93-4. PubMed ID: 17123293
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula.
    Freeman RB, Gish RG, Harper A, Davis GL, Vierling J, Lieblein L, Klintmalm G, Blazek J, Hunter R, Punch J.
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S128-36. PubMed ID: 17123284
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.